Jacobs Levy Equity Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.5K | Sell |
13,501
-3,981
| -23% | -$13.4K | ﹤0.01% | 1017 |
|
|
2025
Q1 | $67.5K | Sell |
17,482
-779
| -4% | -$3.01K | ﹤0.01% | 1054 |
|
|
2024
Q4 | $113K | Sell |
18,261
-262,010
| -93% | -$1.62M | ﹤0.01% | 916 |
|
|
2024
Q3 | $1.51M | Sell |
280,271
-195,987
| -41% | -$1.05M | 0.01% | 658 |
|
|
2024
Q2 | $1.6M | Sell |
476,258
-25,762
| -5% | -$86.3K | 0.01% | 645 |
|
|
2024
Q1 | $2.02M | Sell |
502,020
-47,098
| -9% | -$190K | 0.01% | 596 |
|
|
2023
Q4 | $1.46M | Buy |
+549,118
| New | +$1.46M | 0.01% | 658 |
|
|
2023
Q3 | – | Sell |
-16,100
| Closed | -$101K | – | 987 |
|
|
2023
Q2 | $101K | Buy |
+16,100
| New | +$101K | ﹤0.01% | 946 |
|